scholarly journals Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer

Author(s):  
Dingzhi Wang ◽  
Carlos S. Cabalag ◽  
Nicholas J. Clemons ◽  
Raymond N. DuBois
2001 ◽  
Vol 120 (5) ◽  
pp. A507-A507
Author(s):  
D KANG ◽  
Y WHANG ◽  
J YOO ◽  
I SONG ◽  
J OH ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A660-A660
Author(s):  
Y MURAYAMA ◽  
Y SHINOMURA ◽  
J MIYAGAWA ◽  
H YOSHIDA ◽  
T KIYOHARA ◽  
...  

1955 ◽  
Vol 29 (4) ◽  
pp. 492-493
Author(s):  
George T. Pack ◽  
Morris K. Barrett

2020 ◽  
Author(s):  
S Leyvraz ◽  
J Berlin ◽  
DS Hong ◽  
J Deeken ◽  
V Boni ◽  
...  

2020 ◽  
Vol 04 (04) ◽  
pp. 369-372
Author(s):  
Paul B. Romesser ◽  
Christopher H. Crane

AbstractEvasion of immune recognition is a hallmark of cancer that facilitates tumorigenesis, maintenance, and progression. Systemic immune activation can incite tumor recognition and stimulate potent antitumor responses. While the concept of antitumor immunity is not new, there is renewed interest in tumor immunology given the clinical success of immune modulators in a wide range of cancer subtypes over the past decade. One particularly interesting, yet exceedingly rare phenomenon, is the abscopal response, characterized by a potent systemic antitumor response following localized tumor irradiation presumably attributed to reactivation of antitumor immunity.


2017 ◽  
Vol 26 (2) ◽  
pp. 157-163 ◽  
Author(s):  
Lakshmi Manogna Chintalacheruvu ◽  
Trudy Shaw ◽  
Avanija Buddam ◽  
Osama Diab ◽  
Thamer Kassim ◽  
...  

Gastrointestinal cancer is one of the major causes of death worldwide. Hereditary gastrointestinal cancer syndromes constitute about 5-10% of all cancers. About 20-25% of undiagnosed cases have a possible hereditary component, which is not yet established. In the last few decades, the advance in genomics has led to the discovery of multiple cancer predisposition genes in gastrointestinal cancer. Physicians should be aware of these syndromes to identify high-risk patients and offer genetic testing to prevent cancer death. In this review, we describe clinical manifestations, genetic testing and its challenges, diagnosis and management of the major hereditary gastrointestinal cancer syndromes.Key words:  −  −  −  − .Abbreviations: ACG: American College of Gastroenterology; AFAP: attenuated FAP; APC: adenomatous polyposis coli; CDH1: E-cadherin; CHRPE: congenital hypertrophy of the retinal pigment epithelium; CRC: colorectal cancer; FAMMM: Familial atypical multiple mole melanoma; FAP: Familial adenomatous polyposis; GC: gastric cancer; HDGC: Hereditary diffuse gastric cancer; IHC: immunohistochemical; IPAA: ileal pouch–anal anastomosis; IRA: ileorectal anastomosis; MSI: microsatellite instability; MMR: mismatch repair; miRNA: micro RNA.


1996 ◽  
Vol 7 (5-6) ◽  
pp. 433-456 ◽  
Author(s):  
Eduardo M. Sotomayor ◽  
Ivan Borrello ◽  
Hyam I. Levitsky

2019 ◽  
Vol 74 (1) ◽  
Author(s):  
Juliane Bingener-Casey ◽  
Brent A. Bauer ◽  
Susanne M. Cutshall ◽  
Pamela E. Skaran ◽  
Andrea L. Cheville ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document